Idera Pharmaceuticals reported $6.03M in Current Liabilities for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Aceto ACET:US 20.95M 4.24M
Agenus AGEN:US $ 168.75M 30.38M
Alnylam Pharmaceuticals ALNY:US $ 554.65M 59.82M
Amgen AMGN:US $ 14585M 1716M
Biogen BIIB:US $ 3347.2M 181.4M
Biomarin Pharmaceutical BMRN:US $ 443.34M 13.31M
Cytrx CYTR:US 2.48M 177.19K
Dynavax Technologies DVAX:US $ 204.64M 95.22M
Eli Lilly And LLY:US $ 15093.2M 3379M
Gilead Sciences GILD:US $ 10214M 509M
GlaxoSmithKline GSK:LN 21387M 1112M
Idera Pharmaceuticals IDRA:US $ 6.03M 1.03M
Mirati Therapeutics MRTX:US $ 180.87M 103.76M
Nektar Therapeutics NKTR:US $ 131.02M 7.39M
Sarepta Therapeutics SRPT:US $ 425.02M 60.29M
Seattle Genetics SGEN:US $ 433.83M 44.22M
Ultragenyx Pharmaceutical RARE:US $ 127.07M 0.02M